COVID: 90% of patients treated with new Israeli drug discharged in 5 daysThe Phase II trial for an Israeli COVID drug saw some 29 out of 30 patients, moderate to serious, recover within days.A PATIENT is administered Prof. Nadir Arber’s EXO-CD24 COVID-19 treatment.(photo credit: ICHILOV SPOKESPERSON'S OFFICE)
